You are here

Researchers and Physicians

Stopping The Spread

Dorothy Sipkins, MD, PhD, became fascinated by leukemia during her medical training. She remembers studying a biopsy from an elderly patient who had just had chemotherapy and was in remission. “You couldn’t see any leukemic cells; the bone marrow looked clean,” Sipkins remembers. But she knew that...

Therapy App Aims To Bust Stress

A cancer diagnosis can bring on feelings of anxiety, such as worry, fear, and sadness. For some, the feelings do not subside but worsen to affect daily life. When this happens a patient may develop post-traumatic stress disorder (PTSD), an anxiety disorder usually associated with traumatic events...

Duke Nurse Launches Album For A Cure Campaign

Music has always played an important role in Daniel Nickels’ life. Growing up in Ashland, Oregon, he was surrounded by musicians. His mother taught him to play piano when he was young. By sixteen his dad had Nickels shredding a guitar. He would go on to master other instruments, including the...

Researchers ID Genes That Make Sarcomas Less Aggressive

Duke Cancer Institute and Rice University researchers have identified a network of regulatory genes (the microRNA-200 family, ZEB1, and GRHL2) they believe are driving some sarcomas toward a different cell lineage — a condition that seems to predict better patient outcomes. The culmination of a...

Ovarian Cancer Survivors and Families Help Advance Research

It’s been called the silent killer because it spreads fairly quietly, before causing painful symptoms. By the time many women are diagnosed with ovarian cancer, its already advanced through the abdominal cavity. This is what happened to Gail Parkins, who, at the age of 54, was eventually diagnosed...

Blood Biomarkers ID'd in Drug-Resistant Cancer Tumor Cells

While searching for a non-invasive way to detect prostate cancer cells circulating in blood, Duke Cancer Institute researchers have identified some blood markers associated with tumor resistance to two common hormone therapies. In a study published online this month in the journal Clinical Cancer...

Nationwide Ovarian Cancer Clinical Trial Shows Promise

When IBM IT architect Laura Elzie, 60, was first diagnosed with ovarian cancer three years ago by her long-time primary care physician she was momentarily stunned when she heard, “Some of us never know how we are going to leave this world, but at least you know.” For months she’d been told her pain...

Innovative Research the Focus of DCI Scientific Retreat

Duke Cancer Institute hosted the Fourth Annual DCI Scientific Retreat on Friday, Oct. 28, at Bay 7 in the American Tobacco District in Durham. The event featured the second-annual *O. Michael Colvin Memorial Lecture, which was presented by Levi A. Garraway, MD, PhD, of Harvard Medical School and...

Trial Launches for Veterans with Liver Cancer

Primary liver cancer, also known as hepatocellular carcinoma (HCC), is the world’s third most common cause of cancer death. In the United States, the incidence of HCC is increasing. While surgery is the optimal treatment, less than a third of HCC patients are medically fit for surgery or liver...

Pages